Literature DB >> 1558113

Long-term fluctuation of the visual field in glaucoma.

R J Boeglin1, J Caprioli, M Zulauf.   

Abstract

We examined 756 automated threshold visual fields of 167 eyes of patients with glaucoma to determine the magnitude of the long-term fluctuation at individual test locations. Eyes were grouped into clinically stable or nonstable groups according to predefined clinical criteria. At individual test locations with initial sensitivities of 25 to 30 dB in clinically stable eyes, the 5th to 95th percentile value for subsequent measurements was +/- 4 dB. For initial sensitivities of 20 dB, this 90% range was +/- 6 dB, and for sensitivities 15 dB or less, the 90% range of subsequent values spanned sensitivities from almost zero to normal values. Long-term fluctuation correlated with short-term fluctuation (r = .363, P less than .0005), but not with age or intraocular pressure. There was no correlation of long-term fluctuation with eccentricity after correcting for the decreased sensitivity associated with greater eccentricity. Long-term fluctuation was greater in the nonstable group than in the stable group (P less than .0005). These data provide limits for fluctuation in stable patients with glaucoma, which will help guide clinical decisions about visual field progression.

Entities:  

Mesh:

Year:  1992        PMID: 1558113     DOI: 10.1016/s0002-9394(14)76161-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

1.  Using lasers to image the retina. Interview by Judy Jones.

Authors:  J E Morgan
Journal:  BMJ       Date:  1999-11-13

2.  Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.

Authors:  John L Keltner; Chris A Johnson; Richard A Levine; Juanjuan Fan; Kimberly E Cello; Michael A Kass; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2005-09

Review 3.  Detection of visual field progression in glaucoma with standard achromatic perimetry: a review and practical implications.

Authors:  Kouros Nouri-Mahdavi; Nariman Nassiri; Annette Giangiacomo; Joseph Caprioli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-26       Impact factor: 3.117

4.  How often do patients need visual field tests?

Authors:  A C Viswanathan; R A Hitchings; F W Fitzke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

5.  Formulas for conversion between Octopus and Humphrey threshold values and indices.

Authors:  T Zeyen; M Roche; L Brigatti; J Caprioli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-10       Impact factor: 3.117

6.  Detection of optic disc change with the Heidelberg retina tomograph before confirmed visual field change in ocular hypertensives converting to early glaucoma.

Authors:  D S Kamal; A C Viswanathan; D F Garway-Heath; R A Hitchings; D Poinoosawmy; C Bunce
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

7.  Evaluation of relationship between retinal nerve fiber layer thickness progression and visual field progression in patients with glaucoma.

Authors:  Kaori Tenkumo; Kazuyuki Hirooka; Tetsuya Baba; Eri Nitta; Shino Sato; Fumio Shiraga
Journal:  Jpn J Ophthalmol       Date:  2013-06-25       Impact factor: 2.447

8.  Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2.

Authors:  A C Viswanathan; F W Fitzke; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

9.  Interobserver agreement on visual field progression in glaucoma: a comparison of methods.

Authors:  A C Viswanathan; D P Crabb; A I McNaught; M C Westcott; D Kamal; D F Garway-Heath; F W Fitzke; R A Hitchings
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

10.  Glaucoma detection and evaluation through pattern recognition in standard automated perimetry data.

Authors:  Dariusz Wroblewski; Brian A Francis; Vikas Chopra; A Shahem Kawji; Peter Quiros; Laurie Dustin; R Kemp Massengill
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-05       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.